CA2494658A1 - Utilisation de bupropion pour la fabrication d'un medicament destine au traitement du syndrome des jambes sans repos - Google Patents

Utilisation de bupropion pour la fabrication d'un medicament destine au traitement du syndrome des jambes sans repos Download PDF

Info

Publication number
CA2494658A1
CA2494658A1 CA002494658A CA2494658A CA2494658A1 CA 2494658 A1 CA2494658 A1 CA 2494658A1 CA 002494658 A CA002494658 A CA 002494658A CA 2494658 A CA2494658 A CA 2494658A CA 2494658 A1 CA2494658 A1 CA 2494658A1
Authority
CA
Canada
Prior art keywords
bupropion
administered
use according
rls
restless legs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002494658A
Other languages
English (en)
Inventor
David W. Robertson (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of CA2494658A1 publication Critical patent/CA2494658A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation du bupropion ou d'un sel pharmaceutiquement acceptable de celui-ci dans le traitement du syndrome des jambes sans repos chez les humains.
CA002494658A 2002-08-26 2003-08-22 Utilisation de bupropion pour la fabrication d'un medicament destine au traitement du syndrome des jambes sans repos Abandoned CA2494658A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40594302P 2002-08-26 2002-08-26
US60/405,943 2002-08-26
PCT/US2003/024795 WO2004017951A1 (fr) 2002-08-26 2003-08-22 Utilisation de bupropion pour la fabrication d'un medicament destine au traitement du syndrome des jambes sans repos

Publications (1)

Publication Number Publication Date
CA2494658A1 true CA2494658A1 (fr) 2004-03-04

Family

ID=31946948

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002494658A Abandoned CA2494658A1 (fr) 2002-08-26 2003-08-22 Utilisation de bupropion pour la fabrication d'un medicament destine au traitement du syndrome des jambes sans repos

Country Status (8)

Country Link
US (1) US20040115263A1 (fr)
EP (1) EP1545486A1 (fr)
JP (1) JP2005538147A (fr)
AU (1) AU2003261459A1 (fr)
BR (1) BR0313665A (fr)
CA (1) CA2494658A1 (fr)
MX (1) MXPA05001557A (fr)
WO (1) WO2004017951A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1575565E (pt) * 2003-08-08 2010-03-03 Biovail Lab Int Srl Comprimido de libertação modificada de cloridrato de bupropiona
RU2408368C2 (ru) * 2005-06-27 2011-01-10 Биовэйл Лэборэториз Интернэшнл С.Р.Л. Препараты соли бупропиона с модифицированным высвобождением
US20100010092A1 (en) * 2006-12-19 2010-01-14 Arless Ltd. Use of modafinil to treat restless leg syndrome
AU2010316106B2 (en) 2009-11-06 2015-10-22 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
MX350745B (es) 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
EP2895188B1 (fr) 2012-09-11 2017-11-15 Coherus Biosciences, Inc. Étanercept correctement replié de pureté élevée avec un excellent rendement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ531871A (en) * 2001-09-24 2006-09-29 Ortho Mcneil Pharm Inc Anticonvulsant derivatives such as topiramate useful for the treatment of restless limb syndrome and periodic limb movement disorder

Also Published As

Publication number Publication date
WO2004017951A1 (fr) 2004-03-04
MXPA05001557A (es) 2005-08-19
EP1545486A1 (fr) 2005-06-29
BR0313665A (pt) 2005-06-14
JP2005538147A (ja) 2005-12-15
US20040115263A1 (en) 2004-06-17
AU2003261459A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU747751B2 (en) Use of cabergoline in the treatment of restless legs syndrome
JP5769923B2 (ja) レストレスレッグス症候群の治療のためのラサギリンの使用
US6451860B1 (en) Methods for treating depression and other disorders using optically pure (−)-bupropion
US6476078B2 (en) Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6495605B2 (en) Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (+)-bupropion
JP2003518063A (ja) 麻薬および抗鬱剤から患者を離脱させるためのデキストロメトルファンおよびオキシダーゼ阻害剤の用法
US6297286B1 (en) Therapeutic use and formulation
US20040115263A1 (en) Use of bupropion for treating restless legs syndrome
CA2318960A1 (fr) Utilisations pharmaceutiques de (+)-bupropion optiquement pur
AU4325100A (en) Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
JPWO2008120562A1 (ja) 帯状疱疹後神経痛治療用錠剤および帯状疱疹後神経痛の治療方法
US20040225020A1 (en) Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-) -bupropion
JP2004516271A (ja) 治療法
CA2338326A1 (fr) Procedes et compositions pour le traitement et la prevention des toxicomanies a l'aide de moclobemide
WO2004037238A1 (fr) Nouvelles utilisations de deramciclane

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued